153 results
Page 3 of 8
8-K
EX-1.1
sm9qcq2k33rt
30 Oct 20
Entry into a Material Definitive Agreement
4:40pm
424B5
yu8bmgxa9ch0lqiw2g
30 Oct 20
Prospectus supplement for primary offering
4:32pm
8-K
EX-99.1
pp76zm7nvsmortq7n0
11 Aug 20
Other Events
10:18am
8-K
EX-1.1
shuq0
4 May 20
Fennec Announces Proposed Public Offering of Common Shares
12:00am
424B5
20n78i1afond
1 May 20
Prospectus supplement for primary offering
5:28pm
424B5
3dc3gj3
29 Apr 20
Prospectus supplement for primary offering
4:48pm
8-K
EX-99.1
b7c3xjb
13 Apr 20
Fennec Pharmaceuticals Announces Fda Filing Acceptance and Priority Review of New Drug Application for Pedmarktm
5:09pm
8-K
EX-99.1
m2hb4
11 Feb 20
PEDMARKTM1 is Being Developed for Prevention of Cisplatin-Induced Hearing Loss in Children
2:17pm